Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Correction

Correction: Sleiman et al., Mithramycin Is a Gene-Selective Sp1 Inhibitor That Identifies a Biological Intersection between Cancer and Neurodegeneration

Journal of Neuroscience 9 May 2012, 32 (19) 6743; DOI: https://doi.org/10.1523/JNEUROSCI.1205-12.2012
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1523/JNEUROSCI.1205-12.2012
Published By 
Society for Neuroscience
History 
  • First published May 9, 2012.
  • Version of record published May 9, 2012.

Author Information

Author contributions

Disclosures

Online Impact

 

Article usage

Select a custom date range for the past year
E.g., 2022-06-20
to
E.g., 2022-06-20

Article usage: May 2012 to May 2022

AbstractFullPdf
May 2012059342
Jun 20120894
Jul 20120537
Aug 20120381
Sep 20120321
Oct 20120255
Nov 20120292
Dec 20120203
Total 2012087965
Jan 20130265
Feb 20130225
Mar 20130133
Apr 20130142
May 20130124
Jun 20130263
Jul 20130120
Aug 2013090
Sep 20130180
Oct 20130131
Nov 20130183
Dec 2013021
Total 2013018527
Jan 2014073
Feb 2014082
Mar 20140143
Apr 2014080
May 20140131
Jun 2014010
Jul 20140140
Aug 2014051
Sep 2014040
Oct 20140110
Nov 2014091
Dec 2014091
Total 2014010312
Jan 2015091
Feb 2015071
Mar 2015071
Apr 20150121
May 20150130
Jun 20150134
Jul 20150110
Aug 2015051
Sep 2015061
Oct 20150160
Nov 2015081
Dec 2015071
Total 2015011412
Jan 2016081
Feb 2016075
Mar 2016074
Apr 2016040
May 2016040
Jun 2016011
Jul 2016080
Aug 20160151
Sep 20160151
Oct 20160101
Nov 2016031
Dec 2016042
Total 201608617
Jan 20170121
Feb 2017050
Mar 20170122
Apr 2017093
May 2017075
Jun 2017021
Jul 2017041
Aug 2017031
Sep 2017063
Oct 2017092
Nov 2017081
Dec 2017050
Total 201708220
Jan 20180132
Feb 2018082
Mar 2018050
Apr 20180100
May 20180111
Jun 20180180
Jul 2018091
Aug 2018070
Sep 20180100
Oct 20180111
Nov 2018071
Dec 2018040
Total 201801138
Jan 2019030
Feb 2019030
Mar 2019022
Apr 2019082
May 2019022
Jun 2019052
Jul 2019003
Aug 2019035
Sep 2019040
Oct 2019043
Nov 2019085
Dec 2019031
Total 201904525
Jan 2020092
Feb 2020023
Mar 2020054
Apr 2020021
May 2020032
Jun 2020066
Jul 2020034
Aug 2020031
Sep 20200810
Oct 2020052
Nov 2020063
Dec 20200101
Total 202006239
Jan 20210102
Feb 2021056
Mar 20210111
Apr 2021072
May 2021065
Jun 20210105
Jul 20210413
Aug 2021076
Sep 2021055
Oct 202101116
Nov 20210515
Dec 2021071
Total 202108877
Jan 20220161
Feb 2022082
Mar 2022081
Apr 2022081
May 20220210
Total 202204215
Total01799317
Back to top

In this issue

The Journal of Neuroscience: 32 (19)
Journal of Neuroscience
Vol. 32, Issue 19
9 May 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Advertising (PDF)
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Correction: Sleiman et al., Mithramycin Is a Gene-Selective Sp1 Inhibitor That Identifies a Biological Intersection between Cancer and Neurodegeneration
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Correction: Sleiman et al., Mithramycin Is a Gene-Selective Sp1 Inhibitor That Identifies a Biological Intersection between Cancer and Neurodegeneration
Journal of Neuroscience 9 May 2012, 32 (19) 6743; DOI: 10.1523/JNEUROSCI.1205-12.2012

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Correction: Sleiman et al., Mithramycin Is a Gene-Selective Sp1 Inhibitor That Identifies a Biological Intersection between Cancer and Neurodegeneration
Journal of Neuroscience 9 May 2012, 32 (19) 6743; DOI: 10.1523/JNEUROSCI.1205-12.2012
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • Correction: Sequerra, Goyal et al., “NMDA Receptor Signaling Is Important for Neural Tube Formation and for Preventing Antiepileptic Drug-Induced Neural Tube Defects”
  • Correction: Darbelli et al., “Quaking Regulates Neurofascin 155 Expression for Myelin and Axoglial Junction Maintenance”
  • Correction: Personius et al., “Neuromuscular NMDA Receptors Modulate Developmental Synapse Elimination”
Show more Correction
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2022 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.